首页> 外文期刊>BioMed research international >Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT
【24h】

Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT

机译:低剂量区域约束的基于螺旋层析成像的全乳腺放疗以及与切向场内IMRT的剂量学比较

获取原文
           

摘要

Background and Purpose.To present a novel helical TomoTherapy-based method for whole breast radiotherapy that has better dosimetry and also has acceptable low-dose regions for lungs, heart, and contralateral breast compared with tangential field-in-field IMRT (FIF-IMRT).Material and Methods.Ten patients with left-side breast cancer were planned with low-dose-area-constrained helical TomoTherapy (LDC-HT) and FIF-IMRT. Dosimetry was compared for all techniques.Results.Coverage of the whole breast was adequate with both techniques. Homogeneity index (HI) and conformity index (CI) were better with LDC-HT. LDC-HT showed dosimetry advantages over FIF-IMRT for ipsilateral lung and heart in not only high-dose levels but also in low-dose levels such asV10 GyandV5 Gy. For contralateral lung, both techniques can provide good protection, although the mean dose of LDC-HT is higher than that of FIF-IMRT.Conclusions.With LDC-HT, we obtained adequate target coverage, better HI and CI of target volume, better sparing of organs at risk, and acceptably low-dose areas compared with FIF-IMRT. LDC-HT could be a feasible method in whole breast radiotherapy. Clinical benefits of LDC-HT need further investigation.
机译:背景与目的:提出一种基于螺旋线TomoTherapy的全乳放射疗法新方法,与切向场IMRT(FIF-IMRT)相比,该方法具有更好的剂量学并且还具有可接受的肺,心脏和对侧乳腺低剂量区域材料与方法。计划对10例左侧乳腺癌患者进行低剂量区域限制的螺旋TomoTherapy(LDC-HT)和FIF-IMRT。比较了所有技术的剂量测定法。结果:两种技术都覆盖了整个乳房。 LDC-HT的同质性指数(HI)和合格指数(CI)更好。对于同侧肺和心脏,LDC-HT在FIF-IMRT方面显示出剂量学优势,不仅在高剂量水平,而且在低剂量水平(例如V10 Gy和V5 Gy)方面。对于对侧肺,尽管LDC-HT的平均剂量高于FIF-IMRT,这两种技术都可以提供良好的保护。结论。通过LDC-HT,我们可以获得足够的靶标覆盖率,更好的目标体积的HI和CI,更好的目标体积。与FIF-IMRT相比,保留了处于危险中的器官以及低剂量的区域。 LDC-HT在全乳放疗中可能是一种可行的方法。 LDC-HT的临床益处需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号